Cargando…

Antitumor activity of colloidal silver on MCF-7 human breast cancer cells

BACKGROUND: Colloidal silver has been used as an antimicrobial and disinfectant agent. However, there is scarce information on its antitumor potential. The aim of this study was to determine if colloidal silver had cytotoxic effects on MCF-7 breast cancer cells and its mechanism of cell death. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Franco-Molina, Moisés A, Mendoza-Gamboa, Edgar, Sierra-Rivera, Crystel A, Gómez-Flores, Ricardo A, Zapata-Benavides, Pablo, Castillo-Tello, Paloma, Alcocer-González, Juan Manuel, Miranda-Hernández, Diana F, Tamez-Guerra, Reyes S, Rodríguez-Padilla, Cristina
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996348/
https://www.ncbi.nlm.nih.gov/pubmed/21080962
http://dx.doi.org/10.1186/1756-9966-29-148
_version_ 1782193189731434496
author Franco-Molina, Moisés A
Mendoza-Gamboa, Edgar
Sierra-Rivera, Crystel A
Gómez-Flores, Ricardo A
Zapata-Benavides, Pablo
Castillo-Tello, Paloma
Alcocer-González, Juan Manuel
Miranda-Hernández, Diana F
Tamez-Guerra, Reyes S
Rodríguez-Padilla, Cristina
author_facet Franco-Molina, Moisés A
Mendoza-Gamboa, Edgar
Sierra-Rivera, Crystel A
Gómez-Flores, Ricardo A
Zapata-Benavides, Pablo
Castillo-Tello, Paloma
Alcocer-González, Juan Manuel
Miranda-Hernández, Diana F
Tamez-Guerra, Reyes S
Rodríguez-Padilla, Cristina
author_sort Franco-Molina, Moisés A
collection PubMed
description BACKGROUND: Colloidal silver has been used as an antimicrobial and disinfectant agent. However, there is scarce information on its antitumor potential. The aim of this study was to determine if colloidal silver had cytotoxic effects on MCF-7 breast cancer cells and its mechanism of cell death. METHODS: MCF-7 breast cancer cells were treated with colloidal silver (ranged from 1.75 to 17.5 ng/mL) for 5 h at 37°C and 5% CO(2 )atmosphere. Cell Viability was evaluated by trypan blue exclusion method and the mechanism of cell death through detection of mono-oligonucleosomes using an ELISA kit and TUNEL assay. The production of NO, LDH, and Gpx, SOD, CAT, and Total antioxidant activities were evaluated by colorimetric assays. RESULTS: Colloidal silver had dose-dependent cytotoxic effect in MCF-7 breast cancer cells through induction of apoptosis, shown an LD(50 )(3.5 ng/mL) and LD(100 )(14 ng/mL) (*P < 0.05), significantly decreased LDH (*P < 0.05) and significantly increased SOD (*P < 0.05) activities. However, the NO production, and Gpx, CAT, and Total antioxidant activities were not affected in MCF-7 breast cancer cells. PBMC were not altered by colloidal silver. CONCLUSIONS: The present results showed that colloidal silver might be a potential alternative agent for human breast cancer therapy.
format Text
id pubmed-2996348
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29963482010-12-03 Antitumor activity of colloidal silver on MCF-7 human breast cancer cells Franco-Molina, Moisés A Mendoza-Gamboa, Edgar Sierra-Rivera, Crystel A Gómez-Flores, Ricardo A Zapata-Benavides, Pablo Castillo-Tello, Paloma Alcocer-González, Juan Manuel Miranda-Hernández, Diana F Tamez-Guerra, Reyes S Rodríguez-Padilla, Cristina J Exp Clin Cancer Res Research BACKGROUND: Colloidal silver has been used as an antimicrobial and disinfectant agent. However, there is scarce information on its antitumor potential. The aim of this study was to determine if colloidal silver had cytotoxic effects on MCF-7 breast cancer cells and its mechanism of cell death. METHODS: MCF-7 breast cancer cells were treated with colloidal silver (ranged from 1.75 to 17.5 ng/mL) for 5 h at 37°C and 5% CO(2 )atmosphere. Cell Viability was evaluated by trypan blue exclusion method and the mechanism of cell death through detection of mono-oligonucleosomes using an ELISA kit and TUNEL assay. The production of NO, LDH, and Gpx, SOD, CAT, and Total antioxidant activities were evaluated by colorimetric assays. RESULTS: Colloidal silver had dose-dependent cytotoxic effect in MCF-7 breast cancer cells through induction of apoptosis, shown an LD(50 )(3.5 ng/mL) and LD(100 )(14 ng/mL) (*P < 0.05), significantly decreased LDH (*P < 0.05) and significantly increased SOD (*P < 0.05) activities. However, the NO production, and Gpx, CAT, and Total antioxidant activities were not affected in MCF-7 breast cancer cells. PBMC were not altered by colloidal silver. CONCLUSIONS: The present results showed that colloidal silver might be a potential alternative agent for human breast cancer therapy. BioMed Central 2010-11-16 /pmc/articles/PMC2996348/ /pubmed/21080962 http://dx.doi.org/10.1186/1756-9966-29-148 Text en Copyright ©2010 Franco-Molina et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Franco-Molina, Moisés A
Mendoza-Gamboa, Edgar
Sierra-Rivera, Crystel A
Gómez-Flores, Ricardo A
Zapata-Benavides, Pablo
Castillo-Tello, Paloma
Alcocer-González, Juan Manuel
Miranda-Hernández, Diana F
Tamez-Guerra, Reyes S
Rodríguez-Padilla, Cristina
Antitumor activity of colloidal silver on MCF-7 human breast cancer cells
title Antitumor activity of colloidal silver on MCF-7 human breast cancer cells
title_full Antitumor activity of colloidal silver on MCF-7 human breast cancer cells
title_fullStr Antitumor activity of colloidal silver on MCF-7 human breast cancer cells
title_full_unstemmed Antitumor activity of colloidal silver on MCF-7 human breast cancer cells
title_short Antitumor activity of colloidal silver on MCF-7 human breast cancer cells
title_sort antitumor activity of colloidal silver on mcf-7 human breast cancer cells
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996348/
https://www.ncbi.nlm.nih.gov/pubmed/21080962
http://dx.doi.org/10.1186/1756-9966-29-148
work_keys_str_mv AT francomolinamoisesa antitumoractivityofcolloidalsilveronmcf7humanbreastcancercells
AT mendozagamboaedgar antitumoractivityofcolloidalsilveronmcf7humanbreastcancercells
AT sierrariveracrystela antitumoractivityofcolloidalsilveronmcf7humanbreastcancercells
AT gomezfloresricardoa antitumoractivityofcolloidalsilveronmcf7humanbreastcancercells
AT zapatabenavidespablo antitumoractivityofcolloidalsilveronmcf7humanbreastcancercells
AT castillotellopaloma antitumoractivityofcolloidalsilveronmcf7humanbreastcancercells
AT alcocergonzalezjuanmanuel antitumoractivityofcolloidalsilveronmcf7humanbreastcancercells
AT mirandahernandezdianaf antitumoractivityofcolloidalsilveronmcf7humanbreastcancercells
AT tamezguerrareyess antitumoractivityofcolloidalsilveronmcf7humanbreastcancercells
AT rodriguezpadillacristina antitumoractivityofcolloidalsilveronmcf7humanbreastcancercells